65,437 trials
Papillomavirus Infections
Primary: Geometric Mean Titer (GMT) of Anti-HPV 6, 11, 16 , 18 at Day 1 and Month 7 (1 Month After Completion of Administration of a 6-month 3-dose Regimen of Vaccines) — 7; 7…
Diabetic Macular Edema
Primary: Change In Visual Acuity [Measured With Electronic-Early Treatment Diabetic Retinopathy Study (E-ETDRS)]Baseline to 2 Years. — 1; -2; -3 Letter score — p=0.02
Non-small Cell Lung Cancer · Mesothelioma · Lung Neoplasms
Primary: Overview of Adverse Events — 28; 23; 12; 1 participants
Multiple Sclerosis
Primary: Number of Participants Who Were Neutralising Antibody (NAb) Positive at the Week 96 Visit. — 45 participants
Emergent Coronary Procedure
Primary: Occurrence of Contrast-induced Nephropathy — 1; 8 participants
Excessive Sleepiness
Primary: Mean Sleep Latency (Minutes) From the Multiple Sleep Latency Test (MSLT)- Average of Four Scheduled Naps Across Days 1 and 2 — 7.7; 11.7; 4.8 Minutes — p=<0.0001
Ulcerative Colitis
Primary: Clinical Recurrence of Ulcerative Colitis (UC) During the Maintenance Phase at 6 Months — 46; 150; 11 participants
Gastric Ulcer
Primary: The Percentage of Subjects Whose Gastric Ulcer(s) (GUs) Was (Were) Healed at Week 4 After Treatment With Esomeprazole 20 mg qd and Ranitidine 150 mg Bid in Patients…
Tobacco Dependence
Primary: Maximum Plasma Concentration — 3.04; 4.94; 8.63; 6.44 (ng/ml)
Hypertension
Primary: Change From Baseline in Segmental Bioimpedance Measurements at 10 Kilohertz (KHz) at Week 2 — -7.9; 3.8 Ohms — p=0.001
Chronic Disease · Hypertension · Back Pain
Primary: SF-36 Physical Component — 42.6; 43.1 units on a scale
Smoking Cessation
Primary: Number of Participants With Non-serious Adverse Events (AEs) or Serious Adverse Events (SAEs) — 131; 7 participants
Type 2 Diabetes
Primary: Absolute Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) Level to Week 12 Last Observation Carried Forward (LOCF) — 8.09; 8.45; 7.80; 7.63 Percent — p=0.007
Cerebral Ischemia
Primary: Harm to Skin From Attachment of Sensor to Forehead: Cuts, Bruising, Rash or Allergic Reactions to Adhesive. — 0; 14 Participants
Schizophrenia · Metabolic Syndrome X
Primary: Metabolic Syndrome Parameter Body Mass Index (BMI) — 26.3; 26.6; 26.9 kg/m*m (kilograms per meter squared) — p=<0.001